{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:00:51Z","timestamp":1793278851149,"version":"4.5.0"},"reference-count":146,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"12","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2024,12,17]]},"DOI":"10.1167\/tvst.13.12.28","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:30:47Z","timestamp":1734453047000},"page":"28","source":"Crossref","is-referenced-by-count":16,"title":["Inherited Retinal Degenerations and Non-Neovascular Age-Related Macular Degeneration: Progress and Unmet Needs"],"prefix":"10.1167","volume":"13","author":[{"given":"Jacque L.","family":"Duncan","sequence":"first","affiliation":[{"name":"Wayne and Gladys Valley Center for Vision, Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Bowman","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Laster","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Gelfman","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Birch","sequence":"additional","affiliation":[{"name":"Rose-Silverthorne Retinal Degenerations Laboratory, Retina Foundation of the Southwest, Dallas, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon E.","family":"Boye","sequence":"additional","affiliation":[{"name":"Division of Cellular and Molecular Therapy, Department of Pediatrics, University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Daiger","sequence":"additional","affiliation":[{"name":"Human Genetics Center, Epidemiology Dept., School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian","family":"del Priore","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"Zack","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Handa","sequence":"additional","affiliation":[{"name":"Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Foundation Fighting Blindness Scientific Advisory Board","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"2","key":"bib1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"issue":"1673","key":"bib2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.58347\/tml.2023.1673a","article-title":"Pegcetacoplan (Syfovre) for geographic atrophy in age-related macular degeneration","volume":"65","year":"2023","journal-title":"Me\u00b4d Lett Drugs Ther"},{"issue":"10411","key":"bib3","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"},{"issue":"10097","key":"bib4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"issue":"7","key":"bib5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1167\/iovs.64.7.39","article-title":"Gene therapy for retinal degenerative diseases: progress, challenges, and future directions","volume":"64","author":"Drag","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"bib6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1167\/tvst.10.4.23","article-title":"Tackling the challenges of product development through a collaborative rare disease network: the foundation fighting blindness consortium","volume":"10","author":"Durham","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"bib7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.12.6.5","article-title":"Overcoming the challenges to clinical development of X-linked retinitis pigmentosa therapies: proceedings of an expert panel","volume":"12","author":"Birch","year":"2023","journal-title":"Transl Vis Sci Technol"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","article-title":"Gene editing for CEP290-associated retinal degeneration","volume":"390","author":"Pierce","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"bib9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ophtha.2023.09.006","article-title":"Single center experience with voretigene neparvovec gene augmentation therapy in RPE65 mutation\u2013associated inherited retinal degeneration in a clinical setting","volume":"131","author":"Lorenz","year":"2024","journal-title":"Ophthalmology"},{"issue":"1","key":"bib10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.oret.2023.08.017","article-title":"Classification and growth rate of chorioretinal atrophy after voretigene neparvovec-Rzyl for RPE65-mediated retinal degeneration","volume":"8","author":"Bommakanti","year":"2024","journal-title":"Ophthalmol Retin"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.oret.2021.03.016","article-title":"Perifoveal chorioretinal atrophy after subretinal voretigene neparvovec-rzyl for RPE65-mediated Leber congenital amaurosis","volume":"6","author":"Gange","year":"2022","journal-title":"Ophthalmol Retin"},{"issue":"5","key":"bib13","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1073\/pnas.1913179117","article-title":"Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases","volume":"117","author":"Hanany","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"bib14","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1167\/iovs.14-16049","article-title":"Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium","volume":"56","author":"Thompson","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"bib15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.7.4.6","article-title":"Inherited retinal degenerations: current landscape and knowledge gaps","volume":"7","author":"Duncan","year":"2018","journal-title":"Transl Vis Sci Technology"},{"issue":"7","key":"bib16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.9.7.2","article-title":"Advancing clinical trials for inherited retinal diseases: recommendations from the Second Monaciano Symposium","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"13","key":"bib17","doi-asserted-by":"publisher","first-page":"10895","DOI":"10.3390\/ijms241310895","article-title":"Clinical characteristics and genetic variants of a large cohort of patients with retinitis pigmentosa using multimodal imaging and next generation sequencing","volume":"24","author":"Sather","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"7","key":"bib18","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.3390\/genes14071413","article-title":"A description of the yield of genetic reinvestigation in patients with inherited retinal dystrophies and previous inconclusive genetic testing","volume":"14","author":"Areblom","year":"2023","journal-title":"Genes"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8669-9","article-title":"Retinal degeneration, methods and protocols","volume":"1834","author":"Khan","year":"2018","journal-title":"Methods Mol Biol"},{"key":"bib20","first-page":"a041287","article-title":"History of finding genes and mutations causing inherited retinal diseases","volume":"14","author":"Daiger","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"5","key":"bib21","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.ajhg.2020.09.002","article-title":"Structural variants create new topological-associated domains and ectopic retinal enhancer-gene contact in dominant retinitis pigmentosa","volume":"107","author":"de Bruijn","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"6588","key":"bib22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.abj6987","article-title":"The complete sequence of a human genome","volume":"376","author":"Nurk","year":"2022","journal-title":"Science"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ydbio.2021.06.005","article-title":"A single-cell guide to retinal development: cell fate decisions of multipotent retinal progenitors in scRNA-seq","volume":"478","author":"Shiau","year":"2021","journal-title":"Dev Biol"},{"issue":"20","key":"bib24","doi-asserted-by":"publisher","first-page":"12170","DOI":"10.3390\/ijms232012170","article-title":"Single-cell transcriptomic profiling in inherited retinal degeneration reveals distinct metabolic pathways in rod and cone photoreceptors","volume":"23","author":"Chen","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"bib25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41594-021-00714-2","article-title":"Can AlphaFold2 predict the impact of missense mutations on structure?","volume":"29","author":"Buel","year":"2022","journal-title":"Nat Struct Mol Biol"},{"issue":"6664","key":"bib26","doi-asserted-by":"publisher","first-page":"eadg7492","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"issue":"8","key":"bib27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","article-title":"Variant interpretation using population databases: Lessons from gnomAD","volume":"43","author":"Gudmundsson","year":"2022","journal-title":"Hum Mutat"},{"issue":"1","key":"bib28","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/humu.22458","article-title":"Comprehensive registration of DNA sequence variants associated with inherited retinal diseases in Leiden open variation databases","volume":"35","author":"Cremers","year":"2014","journal-title":"Hum Mutat"},{"issue":"4","key":"bib29","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41436-018-0267-2","article-title":"Development of clinical domain working groups for the clinical genome resource (ClinGen): lessons learned and plans for the future","volume":"21","author":"Milko","year":"2019","journal-title":"Genet Med"},{"issue":"4","key":"bib30","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.celrep.2019.12.082","article-title":"Integration of eQTL and a single-cell atlas in the human eye identifies causal genes for age-related macular degeneration","volume":"30","author":"Orozco","year":"2020","journal-title":"Cell Rep"},{"issue":"1","key":"bib31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41525-024-00391-2","article-title":"Whole genome sequencing enables new genetic diagnosis for inherited retinal diseases by identifying pathogenic variants","volume":"9","author":"Liu","year":"2024","journal-title":"NPJ Genom Med"},{"issue":"1","key":"bib32","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41598-020-58510-9","article-title":"A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration","volume":"10","author":"Strunz","year":"2020","journal-title":"Sci Rep"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"1343544","DOI":"10.3389\/fncel.2024.1343544","article-title":"Molecular mechanisms underlying inherited photoreceptor degeneration as targets for therapeutic intervention","volume":"18","author":"Bighinati","year":"2024","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"bib34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/bjophthalmol-2020-318452","article-title":"Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions","volume":"106","author":"de Guimaraes","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"e57245","DOI":"10.7554\/eLife.57245","article-title":"Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa","volume":"10","author":"Zhang","year":"2021","journal-title":"Elife"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.preteyeres.2024.101248","article-title":"Pluripotent stem cell-derived models of retinal disease: elucidating pathogenesis, evaluating novel treatments, and estimating toxicity","volume":"100","author":"Kurzawa-Akanbi","year":"2024","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"bib37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/stcltm\/szab010","article-title":"Human retinal organoids provide a suitable tool for toxicological investigations: a comprehensive validation using drugs and compounds affecting the retina","volume":"11","author":"Dorgau","year":"2022","journal-title":"Stem Cell Transl Med"},{"issue":"12","key":"bib38","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.3390\/cells12121575","article-title":"Eupatilin improves cilia defects in human CEP290 ciliopathy models","volume":"12","author":"Corral-Serrano","year":"2023","journal-title":"Cells"},{"issue":"1","key":"bib39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.stemcr.2020.05.007","article-title":"Modeling and rescue of RP2 retinitis pigmentosa using iPSC-derived retinal organoids","volume":"15","author":"Lane","year":"2020","journal-title":"Stem Cell Rep"},{"issue":"6","key":"bib40","doi-asserted-by":"publisher","first-page":"5912","DOI":"10.3390\/ijms24065912","article-title":"Retinal organoids from an AIPL1 CRISPR\/Cas9 knockout cell line successfully recapitulate the molecular features of LCA4 disease","volume":"24","author":"Perdig\u00e3o","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"19-20","key":"bib41","doi-asserted-by":"publisher","first-page":"6505","DOI":"10.1007\/s00018-021-03917-4","article-title":"A look into retinal organoids: methods, analytical techniques, and applications","volume":"78","author":"Afanasyeva","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"bib42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ophtha.2016.12.002","article-title":"Imaging protocols in clinical studies in advanced age-related macular degeneration recommendations from classification of atrophy consensus meetings","volume":"124","author":"Holz","year":"2017","journal-title":"Ophthalmology"},{"issue":"12","key":"bib43","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1097\/IAE.0000000000001258","article-title":"Geographic atrophy","volume":"36","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Retina"},{"issue":"3","key":"bib44","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration Classification of Atrophy Meeting Report 4","volume":"127","author":"Guymer","year":"2020","journal-title":"Ophthalmology"},{"issue":"4","key":"bib45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT Classification of Atrophy Report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"2","key":"bib46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.oret.2022.08.007","article-title":"A deep learning model for automated segmentation of geographic atrophy imaged using swept-source OCT","volume":"7","author":"Pramil","year":"2023","journal-title":"Ophthalmol Retin"},{"issue":"9","key":"bib47","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.ophtha.2018.02.037","article-title":"A deep learning algorithm for prediction of age-related eye disease study severity scale for age-related macular degeneration from color fundus photography","volume":"125","author":"Grassmann","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"bib48","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1038\/s41433-021-01503-3","article-title":"AI-based structure-function correlation in age-related macular degeneration","volume":"35","author":"von der Emde","year":"2021","journal-title":"Eye"},{"issue":"2","key":"bib49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.oret.2021.06.010","article-title":"Self-supervised feature learning and phenotyping for assessing age-related macular degeneration using retinal fundus images","volume":"6","author":"Yellapragada","year":"2022","journal-title":"Ophthalmol Retin"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ajo.2020.12.034","article-title":"Quantification of key retinal features in early and late age-related macular degeneration using deep learning","volume":"226","author":"Liefers","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"bib51","doi-asserted-by":"publisher","first-page":"100428","DOI":"10.1016\/j.xops.2023.100428","article-title":"Deep learning approaches for detecting of nascent geographic atrophy in age-related macular degeneration","volume":"4","author":"Yao","year":"2024","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"bib52","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ophtha.2018.11.015","article-title":"DeepSeeNet: a deep learning model for automated classification of patient-based age-related macular degeneration severity from color fundus photographs","volume":"126","author":"Peng","year":"2019","journal-title":"Ophthalmology"},{"issue":"6","key":"bib53","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.oret.2022.01.021","article-title":"Linking function and structure with ReSensNet predicting retinal sensitivity from OCT using deep learning","volume":"6","author":"Seeb\u00f6ck","year":"2022","journal-title":"Ophthalmol Retin"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"101305","DOI":"10.1016\/j.preteyeres.2024.101305","article-title":"AI in the clinical management of GA: a novel therapeutic universe requires novel tools","volume":"103","author":"Reiter","year":"2024","journal-title":"Prog Retin Eye Res"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajo.2020.05.024","article-title":"Baseline visual field findings in the RUSH2A study: associated factors and correlation with other measures of disease severity","volume":"219","author":"Duncan","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ajo.2022.08.013","article-title":"Baseline microperimetry and OCT in the RUSH2A study: structure-function association and correlation with disease severity","volume":"244","author":"Lad","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"bib57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.9.11.9","article-title":"The RUSH2A study: best-corrected visual acuity, full-field electroretinography amplitudes, and full-field stimulus thresholds at baseline","volume":"9","author":"Birch","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"bib58","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1167\/iovs.63.3.17","article-title":"The RUSH2A study: dark-adapted visual fields in patients with retinal degeneration associated with biallelic variants in the USH2A gene","volume":"63","author":"Birch","year":"2022","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ajo.2023.03.006","article-title":"Change in cone structure over 24 months in USH2A-related retinal degeneration","volume":"252","author":"Duncan","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ajo.2023.02.002","article-title":"Static perimetry in the rate of progression in USH2A-related retinal degeneration (RUSH2A) study: assessment through 2 years","volume":"250","author":"Duncan","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"bib61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/tvst.13.10.15","article-title":"Endpoints and design for clinical trials in USH2A-related retinal degeneration: results and recommendations from the RUSH2A Natural History Study","volume":"13","author":"Maguire","year":"2024","journal-title":"Transl Vis Sci Technol"},{"issue":"6","key":"bib62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/iovs.65.6.5","article-title":"Self-reported functional vision in USH2A-associated retinal degeneration as measured by the Michigan Retinal Degeneration Questionnaire","volume":"65","author":"Parekh","year":"2024","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"bib63","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/humu.24365","article-title":"Tissue-specific genotype\u2013phenotype correlations among USH2A-related disorders in the RUSH2A study","volume":"43","author":"Hufnagel","year":"2022","journal-title":"Hum Mutat"},{"issue":"12","key":"bib64","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1002\/ajmg.a.62437","article-title":"Auditory and olfactory findings in patients with USH2A-related retinal degeneration\u2014Findings at baseline from the rate of progression in USH2A-related retinal degeneration natural history study (RUSH2A)","volume":"185","author":"Iannaccone","year":"2021","journal-title":"Am J Me\u00b4d Genet Part A"},{"issue":"9","key":"bib65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/tvst.11.9.34","article-title":"Phenotyping of ABCA4 retinopathy by machine learning analysis of full-field electroretinography","volume":"11","author":"Glinton","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"bib66","doi-asserted-by":"publisher","first-page":"e155373","DOI":"10.1172\/jci.insight.155373","article-title":"Photoreceptor degeneration in ABCA4-associated retinopathy and its genetic correlates","volume":"7","author":"Pfau","year":"2022","journal-title":"JCI Insight"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"932498","DOI":"10.3389\/fmed.2022.932498","article-title":"Performance of deep learning models in automatic measurement of ellipsoid zone area on baseline optical coherence tomography (OCT) images from the rate of progression of USH2A-Related Retinal Degeneration (RUSH2A) study","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"issue":"7","key":"bib68","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/IAE.0000000000003448","article-title":"Validation of a deep learning-based algorithm for segmentation of the ellipsoid zone on optical coherence tomography images of an USH2A-related retinal degeneration clinical trial","volume":"42","author":"Loo","year":"2022","journal-title":"Retina"},{"issue":"3","key":"bib70","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/13816810.2023.2179074","article-title":"The validation of inherited retinal disease-specific patient-reported outcome measures in adolescent patients","volume":"44","author":"Selvan","year":"2023","journal-title":"Ophthalmic Genet"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2022.11.021","article-title":"Construct validity of inherited retinal disease\u2013specific patient-reported outcome measures","volume":"248","author":"Jayasundera","year":"2023","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"bib72","doi-asserted-by":"publisher","first-page":"a041298","DOI":"10.1101\/cshperspect.a041298","article-title":"Beyond the NEI-VFQ: recent experience in the development and utilization of patient-reported outcomes for inherited retinal diseases","volume":"13","author":"Durham","year":"2023","journal-title":"Cold Spring Harb Perspect Med"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2020.08.032","article-title":"The Michigan Retinal Degeneration Questionnaire: a patient-reported outcome instrument for inherited retinal degenerations","volume":"222","author":"Lacy","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"bib74","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/13816810.2020.1776337","article-title":"Content generation for patient-reported outcome measures for retinal degeneration therapeutic trials","volume":"41","author":"Lacy","year":"2020","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"bib75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13816810.2020.1731836","article-title":"Patient-reported outcome measures in inherited retinal degeneration gene therapy trials","volume":"41","author":"Lacy","year":"2020","journal-title":"Ophthalmic Genet"},{"issue":"4","key":"bib76","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s40123-023-00724-x","article-title":"Development of novel patient-reported outcome (PRO) and observer-reported outcome (ObsRO) instruments in retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA): ViSIO-PRO and ViSIO-ObsRO","volume":"12","author":"Audo","year":"2023","journal-title":"Ophthalmol Ther"},{"issue":"2","key":"bib77","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40291-024-00696-z","article-title":"Exagamglogene autotemcel: first approval","volume":"28","author":"Hoy","year":"2024","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"bib78","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1038\/s41467-022-29550-8","article-title":"Therapeutic homology-independent targeted integration in retina and liver","volume":"13","author":"Tornabene","year":"2022","journal-title":"Nat Commun"},{"issue":"39","key":"bib79","doi-asserted-by":"publisher","first-page":"e2210104119","DOI":"10.1073\/pnas.2210104119","article-title":"Precision genome editing in the eye","volume":"119","author":"Suh","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"bib80","doi-asserted-by":"publisher","first-page":"12375","DOI":"10.3390\/ijms232012375","article-title":"Base and prime editing in the retina\u2014from preclinical research toward human clinical trials","volume":"23","author":"Yee","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"492","key":"bib81","doi-asserted-by":"publisher","first-page":"eaav4523","DOI":"10.1126\/scitranslmed.aav4523","article-title":"Intein-mediated protein trans-splicing expands adeno-associated virus transfer capacity in the retina","volume":"11","author":"Tornabene","year":"2019","journal-title":"Sci Transl Med"},{"issue":"5","key":"bib82","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1089\/hum.2018.156","article-title":"An AAV dual vector strategy ameliorates the Stargardt phenotype in adult Abca4-\/- mice","volume":"30","author":"McClements","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"11","key":"bib83","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1089\/hum.2019.132","article-title":"Dual ABCA4-AAV vector treatment reduces pathogenic retinal A2E accumulation in a mouse model of autosomal recessive Stargardt disease","volume":"30","author":"Dyka","year":"2019","journal-title":"Hum Gene Ther"},{"issue":"1","key":"bib84","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1038\/s41467-023-42386-0","article-title":"mRNA trans-splicing dual AAV vectors for (epi)genome editing and gene therapy","volume":"14","author":"Riedmayr","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"bib85","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1089\/hgtb.2013.212","article-title":"Dual adeno-associated virus vectors result in efficient in vitro and in vivo expression of an oversized gene, MYO7A","volume":"25","author":"Dyka","year":"2014","journal-title":"Hum Gene Ther Method"},{"key":"bib86","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.omtm.2023.02.002","article-title":"Efficacy, pharmacokinetics, and safety in the mouse and primate retina of dual AAV vectors for Usher syndrome type 1B","volume":"28","author":"Ferla","year":"2023","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"bib87","first-page":"25158414221134600","article-title":"RNA-based therapies in inherited retinal diseases","volume":"14","author":"Girach","year":"2022","journal-title":"Ther Adv Ophthalmol"},{"issue":"5","key":"bib88","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/s41591-022-01755-w","article-title":"Intravitreal antisense oligonucleotide sepofarsen in Leber congenital amaurosis type 10: a phase 1b\/2 trial","volume":"28","author":"Russell","year":"2022","journal-title":"Nat Med"},{"issue":"24","key":"bib89","doi-asserted-by":"publisher","first-page":"6274","DOI":"10.3390\/ijms20246274","article-title":"Ataluren for the treatment of Usher syndrome 2A caused by nonsense mutations","volume":"20","author":"Samanta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"bib90","doi-asserted-by":"publisher","first-page":"1092913","DOI":"10.3389\/fnmol.2023.1092913","article-title":"Programmable RNA editing with endogenous ADAR enzymes \u2013 a feasible option for the treatment of inherited retinal disease?","volume":"16","author":"Bellingrath","year":"2023","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"bib91","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.3390\/biology11091338","article-title":"Drug discovery strategies for inherited retinal degenerations","volume":"11","author":"Das","year":"2022","journal-title":"Biology"},{"issue":"9","key":"bib92","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3390\/genes10090654","article-title":"Molecular therapies for inherited retinal diseases\u2014current standing, opportunities and challenges","volume":"10","author":"V\u00e1zquez-Dom\u00ednguez","year":"2019","journal-title":"Genes (Basel)"},{"key":"bib93","doi-asserted-by":"publisher","first-page":"110074","DOI":"10.1016\/j.exer.2024.110074","article-title":"N-acetylcysteine amide and di- N-acetylcysteine amide protect retinal cells in culture via an antioxidant action","volume":"248","author":"Wood","year":"2024","journal-title":"Exp Eye Res"},{"issue":"5","key":"bib94","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.ajpath.2011.01.036","article-title":"N-Acetylcysteine amide (NACA) prevents retinal degeneration by up-regulating reduced glutathione production and reversing lipid peroxidation","volume":"178","author":"Schimel","year":"2011","journal-title":"Am J Pathology"},{"issue":"3","key":"bib95","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1172\/JCI132990","article-title":"Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase 1 trial","volume":"130","author":"Campochiaro","year":"2019","journal-title":"J Clin Invest"},{"key":"bib96","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ajo.2020.08.002","article-title":"Locus-level changes in macular sensitivity in patients with retinitis pigmentosa treated with oral N-acetylcysteine","volume":"221","author":"Kong","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"19","key":"bib97","doi-asserted-by":"publisher","first-page":"6229","DOI":"10.3390\/jcm12196229","article-title":"Updates on emerging interventions for autosomal recessive ABCA4-associated Stargardt disease","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"issue":"7","key":"bib98","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamaophthalmol.2022.1640","article-title":"Long-term outcomes of adding lutein\/zeaxanthin and ?-3 fatty acids to the AREDS supplements on age-related macular degeneration progression","volume":"140","author":"Chew","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"14","key":"bib99","doi-asserted-by":"publisher","first-page":"6513","DOI":"10.1167\/iovs.17-23544","article-title":"Macular degeneration epidemiology: nature-nurture, lifestyle factors, genetic risk, and gene-environment interactions \u2013 the Weisenfeld Award Lecture","volume":"58","author":"Seddon","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib100","first-page":"S0161-6420(24)00425-1","article-title":"Oral antioxidant and lutein\/zeaxanthin supplements slow geographic atrophy progression to the fovea in age-related macular degeneration","author":"Keenan","year":"2024","journal-title":"Ophthalmology"},{"issue":"2","key":"bib101","first-page":"205","article-title":"Occlusive retinal vasculitis after a single injection of pegcetacoplan","volume":"8","author":"Karam","year":"2024","journal-title":"J Vitr Dis"},{"issue":"1","key":"bib102","first-page":"9","article-title":"Retinal vasculitis after intravitreal pegcetacoplan: report from the ASRS Research and Safety in Therapeutics (ReST) Committee","volume":"8","author":"Witkin","year":"2024","journal-title":"J Vitr Dis"},{"key":"bib103","doi-asserted-by":"publisher","first-page":"101999","DOI":"10.1016\/j.ajoc.2024.101999","article-title":"Retinal vasculitis following intravitreal pegcetacoplan administration","volume":"33","author":"Douros","year":"2024","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"3","key":"bib104","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/ICU.0000000000001046","article-title":"Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialists","volume":"35","author":"Vakharia","year":"2024","journal-title":"Curr Opin Ophthalmol"},{"issue":"15","key":"bib105","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.3390\/jcm12155131","article-title":"Complement inhibitors for advanced dry age-related macular degeneration (geographic atrophy): some light at the end of the tunnel?","volume":"12","author":"Cruz-Pimentel","year":"2023","journal-title":"J Clin Med"},{"issue":"7","key":"bib106","first-page":"1064","article-title":"Complement inhibition for geographic atrophy","volume":"43","author":"Spaide","year":"2023","journal-title":"Retina"},{"issue":"9967","key":"bib107","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0140-6736(14)61376-3","article-title":"Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1\/2 studies","volume":"385","author":"Schwartz","year":"2015","journal-title":"Lancet"},{"issue":"9817","key":"bib108","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0140-6736(12)60028-2","article-title":"Embryonic stem cell trials for macular degeneration: a preliminary report","volume":"379","author":"Schwartz","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"bib109","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJMoa1608368","article-title":"Autologous induced stem-cell\u2013derived retinal cells for macular degeneration","volume":"376","author":"Michiko","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"bib110","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.stemcr.2022.01.001","article-title":"Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration","volume":"17","author":"Kashani","year":"2022","journal-title":"Stem Cell Rep"},{"issue":"4","key":"bib111","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/stcltm\/szae004","article-title":"Recent progress in retinal pigment epithelium cell-based therapy for retinal disease","volume":"13","author":"Klymenko","year":"2024","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"bib112","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaophthalmol.2016.5824","article-title":"Survival of transplanted human embryonic stem cell\u2013derived retinal pigment epithelial cells in a human recipient for 22 months","volume":"135","author":"Shim","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"11","key":"bib113","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.ophtha.2018.04.037","article-title":"Transplantation of human embryonic stem cell-derived retinal pigment epithelial cells in macular degeneration","volume":"125","author":"Mehat","year":"2018","journal-title":"Ophthalmology"},{"issue":"8","key":"bib114","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/stcltm\/szad039","article-title":"Progress in stem cells-based replacement therapy for retinal pigment epithelium: in vitro differentiation to in vivo delivery","volume":"12","author":"Gupta","year":"2023","journal-title":"Stem Cells Transl Med"},{"issue":"9","key":"bib115","first-page":"2987","article-title":"Safety and activity of a single, intravitreal injection of human retinal progenitor cells (jCell) for treatment of retinitis pigmentosa (RP)","volume":"59","author":"Kuppermann","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"bib116","first-page":"3240","article-title":"Intravitreal injection of allogeneic human retinal progenitor cells (hRPC) for treatment of retinitis pigmentosa: a prospective randomized controlled phase 2b trial","volume":"62","author":"Liao","year":"2021","journal-title":"Invest Ophthal Vis Sci"},{"issue":"11","key":"bib117","doi-asserted-by":"publisher","first-page":"e53732","DOI":"10.15252\/embr.202153732","article-title":"Nanotube-like processes facilitate material transfer between photoreceptors","volume":"22","author":"Kalargyrou","year":"2021","journal-title":"Embo Rep"},{"issue":"47","key":"bib118","doi-asserted-by":"publisher","first-page":"eabq7219","DOI":"10.1126\/sciadv.abq7219","article-title":"Reprogramming M\u00fcller glia to regenerate ganglion-like cells in adult mouse retina with developmental transcription factors","volume":"8","author":"Todd","year":"2022","journal-title":"Sci Adv"},{"issue":"12","key":"bib119","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1016\/j.stemcr.2023.10.021","article-title":"ASCL1 induces neurogenesis in human M\u00fcller glia","volume":"18","author":"Wohlschlegel","year":"2023","journal-title":"Stem Cell Rep"},{"issue":"21","key":"bib120","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1113\/JP282076","article-title":"Optogenetic approaches to therapy for inherited retinal degenerations","volume":"600","author":"Silva","year":"2022","journal-title":"J Physiology"},{"issue":"23","key":"bib121","doi-asserted-by":"publisher","first-page":"15041","DOI":"10.3390\/ijms232315041","article-title":"Optogenetic therapy for visual restoration","volume":"23","author":"Sakai","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"bib122","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/biom12020269","article-title":"Advances in ophthalmic optogenetics: approaches and applications","volume":"12","author":"Prosseda","year":"2022","journal-title":"Biomolecules"},{"issue":"7","key":"bib123","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","article-title":"Partial recovery of visual function in a blind patient after optogenetic therapy","volume":"27","author":"Sahel","year":"2021","journal-title":"Nat Med"},{"key":"bib124","first-page":"2137","article-title":"Longitudinal BCVA analysis of low- or high-dose MCO-010 mutation agnostic optogenetic therapy for retinitis pigmentosa: 12-month results from a Phase 2b\/3 randomized, sham-controlled, patient- and assessor-masked clinical trial (RESTORE)","volume":"65","author":"Ho","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"16","key":"bib125","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1016\/j.cub.2015.07.029","article-title":"Restoration of vision with ectopic expression of human rod opsin","volume":"25","author":"Cehajic-Kapetanovic","year":"2015","journal-title":"Curr Biol"},{"issue":"6","key":"bib126","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.ymthe.2019.04.002","article-title":"Improved CoChR variants restore visual acuity and contrast sensitivity in a mouse model of blindness under ambient light conditions","volume":"27","author":"Ganjawala","year":"2019","journal-title":"Mol Ther"},{"key":"bib127","article-title":"High-sensitivity vision restoration via ectopic expression of chimeric rhodopsin in mice [published online ahead of print August 18, 2022]","author":"Katada","journal-title":"bioRxiv Preprint"},{"issue":"1","key":"bib128","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40942-023-00498-1","article-title":"An update on visual prosthesis","volume":"9","author":"Ramirez","year":"2023","journal-title":"Int J Retin Vitr"},{"issue":"10","key":"bib129","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.ophtha.2016.06.049","article-title":"Five-year safety and performance results from the Argus II Retinal Prosthesis System Clinical Trial","volume":"123","author":"da Cruz","year":"2016","journal-title":"Ophthalmology"},{"issue":"10","key":"bib131","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1167\/tvst.10.10.12","article-title":"A second-generation (44-channel) suprachoroidal retinal prosthesis: interim clinical trial results","volume":"10","author":"Petoe","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"10","key":"bib132","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00417-007-0563-z","article-title":"Evaluation of phosphenes elicited by extraocular stimulation in normals and by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa","volume":"245","author":"Fujikado","year":"2007","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"9","key":"bib133","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00417-018-3982-0","article-title":"Light localization with low-contrast targets in a patient implanted with a suprachoroidal\u2013transretinal stimulation retinal prosthesis","volume":"256","author":"Endo","year":"2018","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"1","key":"bib134","doi-asserted-by":"publisher","first-page":"100525","DOI":"10.1016\/j.xops.2024.100525","article-title":"A second-generation (44-channel) suprachoroidal retinal prosthesis: a single-arm clinical trial of feasibility","volume":"5","author":"Petoe","year":"2025","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"bib135","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"11","key":"bib136","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.oret.2021.01.012","article-title":"Fundus autofluorescence in neovascular age-related macular degeneration: a clinicopathologic correlation relevant to macular atrophy","volume":"5","author":"Chen","year":"2021","journal-title":"Ophthalmol Retin"},{"issue":"7","key":"bib137","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1167\/iovs.19-27156","article-title":"Treatment potential for macular cone vision in Leber congenital amaurosis due to CEP290 or NPHP5 mutations: predictions from artificial intelligence","volume":"60","author":"Sumaroka","year":"2019","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"bib138","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajo.2020.04.003","article-title":"Determinants of cone and rod functions in geographic atrophy: AI-based structure-function correlation","volume":"217","author":"Pfau","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"bib139","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/IAE.0000000000002337","article-title":"Mesopic and dark-adapted two-color fundus-controlled perimetry in geographic atrophy secondary to age-related macular degeneration","volume":"40","author":"Pfau","year":"2020","journal-title":"Retina"},{"issue":"2","key":"bib140","doi-asserted-by":"publisher","first-page":"100419","DOI":"10.1016\/j.xops.2023.100419","article-title":"Targeted high-density microperimetry testing of nascent geographic atrophy in age-related macular degeneration","volume":"4","author":"Wu","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"bib141","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2147\/OPTH.S292527","article-title":"A virtual reality orientation and mobility test for inherited retinal degenerations: testing a proof-of-concept after gene therapy","volume":"15","author":"Aleman","year":"2021","journal-title":"Clin Ophthalmol (Auckl, NZ)"},{"issue":"1","key":"bib142","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12886-022-02475-y","article-title":"Mobility test to assess functional vision in dark-adapted patients with Leber congenital amaurosis","volume":"22","author":"Roman","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"bib143","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1167\/tvst.9.10.5","article-title":"Validation of a vision-guided mobility assessment for RPE65-associated retinal dystrophy","volume":"9","author":"Kumaran","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"bib144","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Prim"},{"issue":"12","key":"bib145","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.ophtha.2019.07.022","article-title":"Prevalence, risk, and genetic association of reticular pseudodrusen in Age-related Macular Degeneration Age-Related Eye Disease Study 2 Report 21","volume":"126","author":"Domalpally","year":"2019","journal-title":"Ophthalmology"},{"issue":"19","key":"bib146","doi-asserted-by":"publisher","first-page":"e2117553119","DOI":"10.1073\/pnas.2117553119","article-title":"Single-cell\u2013resolution map of human retinal pigment epithelium helps discover subpopulations with differential disease sensitivity","volume":"119","author":"Ortolan","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib12","article-title":"World Health Organization: Blindness and vision impairment","year":"2023"},{"key":"bib69","volume-title":"BEST (Biomarkers, EndpointS, and other Tools) Resource [Internet]","author":"FDA-NIH Biomarker Working Group","year":"2016"},{"key":"bib130","article-title":"Second Sight's implant technology gets a second chance","author":"Harris"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2802373","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T16:30:52Z","timestamp":1734453052000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2802373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":146,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,2]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.13.12.28","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,17]]}}}